Viewing Study NCT06213168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:29 PM
Ignite Modification Date: 2026-01-29 @ 10:58 AM
Study NCT ID: NCT06213168
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-19
First Post: 2023-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Therapy Versus High Flow Nasal Cannula Oxygen Therapy Alone in Patients With de Novo Acute Hypoxemic Respiratory Failure: a Prospective, Randomized Controlled Trial.
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None De Novo Hypoxemic Acute Respiratory Failure (hARF) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Continuous positive airway pressure View
None High flow nasal cannula oxygen therapy View
None De novo hypoxemic acute respiratory failure View
None Intensive care unit View
None Mortality View
None Mechanical ventilation View
None Non-invasive ventilation View